Covis Pharmaceuticals

Covis Pharmaceuticals products

• Altoprev® — lovastatin extended-release
  Indication: lowering cholesterol (dyslipidemia) in adults (statin therapy)

• Alvesco® — ciclesonide inhalation aerosol
  Indication: maintenance therapy for asthma (inhaled corticosteroid)

• Betapace® / Betapace AF® — sotalol
  Indication: treatment of arrhythmias (atrial fibrillation/flutter control)

• Duaklir® Pressair® — aclidinium bromide/formoterol
  Indication: long-term maintenance treatment of COPD (LAMA/LABA combo)

• Feraheme® — ferumoxytol
  Indication: intravenous iron therapy for iron deficiency anemia in patients with chronic kidney disease

• Lanoxin® — digoxin
  Indication: heart failure and certain arrhythmias

• Omnaris® — ciclesonide nasal spray
  Indication: allergic rhinitis (nasal allergy relief)

• Prilosec® — omeprazole
  Indication: acid-related disorders like GERD and heartburn (proton pump inhibitor)

• Sular® — nisoldipine
  Indication: hypertension management (calcium channel blocker)

• Tudorza® Pressair® — aclidinium bromide
  Indication: maintenance treatment of COPD (long-acting muscarinic antagonist)